Abstract
The project proposes an innovative approach for the development and optimization of the production of the human monoclonal antibody Serrumab, designed to neutralize toxins from the venom of the Tityus serrulatus scorpion. This venom is responsible for a significant number of severe envenomation cases in Brazil, posing a critical challenge to public health.Serrumab, whose patent was grante…